Avalo Therapeutics (AVTX) Current Taxes (2017 - 2019)

Avalo Therapeutics (AVTX) has 3 years of Current Taxes data on file, last reported at $551671.0 in Q4 2019.

• Quarterly Current Taxes fell 72.85% year-over-year to $551671.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $551671.0 (down 72.85% YoY) and the FY2019 annual result came in at $551671.0, down 72.85% from the prior year.
• Current Taxes retreated to $551671.0 in Q4 2019, from $1.0 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $3.2 million in Q3 2017 to a low of $551671.0 in Q4 2019.
• A 3-year average of $1.9 million and a median of $2.1 million in 2018 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2018 — Current Taxes retreated 10.04% — and 2019, when it sank 72.85%.
• Tracing AVTX's Current Taxes over 3 years: stood at $2.3 million in 2017, then dropped by 10.04% to $2.0 million in 2018, then slumped by 72.85% to $551671.0 in 2019.
• The last three Current Taxes figures came in at $551671.0 (Q4 2019), $1.0 million (Q3 2019), and $1.4 million (Q2 2019), per Business Quant data.